Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E-Mart | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩2.25T | -3.9x | 0.01 | ₩83,000 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.4% Upside | Upgrade to Pro+ | |
BGF Retail | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩1.75T | 9x | -28.05 | ₩100,800 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.9% Upside | Upgrade to Pro+ | |
Gs Retail | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩1.18T | -32.3x | 0.37 | ₩14,290 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.1% Upside | Upgrade to Pro+ | |
Hyundai Green Food | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩524.35B | 6.9x | 0.12 | ₩15,490 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.1% Upside | Upgrade to Pro+ | |
SPC Samlip | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩490.37B | 5.9x | 0.08 | ₩60,100 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.1% Upside | Upgrade to Pro+ | |
Curexo | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩394.46B | -15.9x | ₩9,610 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CJ Freshway | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩302.13B | 9.9x | -0.23 | ₩24,950 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.8% Upside | Upgrade to Pro+ | |
Kyochon | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩260.82B | 134.4x | -1.41 | ₩5,150 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinsegae Food | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩129.33B | 10.7x | 2.17 | ₩33,600 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.7% Upside | Upgrade to Pro+ | |
Boratr | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩70.6B | 7.1x | 10.5 | ₩10,780 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seouleaguer | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩60.16B | 5.1x | 0.04 | ₩708 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KBio Company | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩29.45B | -4.4x | -0.08 | ₩255 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CuroHoldings | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩16.92B | -0.5x | 0.01 | ₩740 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |